Animal data:: The contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo

被引:147
作者
Lenneraes, Hans [1 ]
机构
[1] Uppsala Univ, Dept Pharm, S-75123 Uppsala, Sweden
关键词
human intestinal absorption; intestinal permeability; bioavailability; intestinal efflux; P-glycoprotein; biopharmaceutics classification system; model correlations; absorption prediction; ADME; pharmacokinetics;
D O I
10.1016/j.addr.2007.06.016
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Oral administration dominates contemporary drug therapy and will most likely continue to do so as it is considered to be safe, efficient and easily accessible with minimal discomfort to the patient compared to other routes of administration such as intramuscular, subcutaneous, rectal and pulmonary delivery. However, despite these advantages, many of the mechanisms of drug uptake following oral administration remain to be fully characterized. In drug discovery and preclinical development there is a strong demand for the accurate and rapid characterization of processes such as absorption, distribution, metabolism and excretion. These biopharmaceutical/pharmacokinetic variables should also be related to pharmacodynamic and toxicological variables such potency and duration of effect. Although these processes are highly dynamic and complex, they are not yet fully characterized in vivo. Various in vitro pharmacokinetic screening methodologies have significantly increased the amount of experimental data generated in this part of the drug discovery process. In addition to these techniques, there is a strong need for in silico methods that may be used to accurately predict pharmacokinetic properties from molecular structure. For instance, pharmacokinetic filters that can sort out compounds with undesirable pharmacokinetic properties can be applied to virtual screening or compound design to reduce attrition rates. The aim of this review is to summarize reported human permeability values and to evaluate how they correlate to corresponding rat intestinal permeability data obtained in single-pass perfusion and Ussing Chamber experiments. The human permeability data are based on direct in vivo determinations in the human gastrointestinal tract with a single-pass perfusion system. The focus of this attention is particularly justified as the availability of directly determined in vivo permeability data in the literature is limited. In addition, there is a shortage of intestinal permeability studies in other ammals. (C) 2007 Published by Elsevier B.V.
引用
收藏
页码:1103 / 1120
页数:18
相关论文
共 144 条
[1]
Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques [J].
Afzelius, L ;
Raubacher, F ;
Karlén, A ;
Jorgensen, FS ;
Andersson, TB ;
Masimirembwa, CM ;
Zamora, I .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (11) :1218-1229
[2]
State-of-the-art tools for computational site of metabolism predictions: Comparative analysis, mechanistical insights, and future applications [J].
Afzelius, Lovisa ;
Arnby, Catrin Hasselgren ;
Broo, Anders ;
Carlsson, Lars ;
Isaksson, Christine ;
Jurva, Ulrik ;
Kjellander, Britta ;
Kolmodin, Karin ;
Nilsson, Kristina ;
Raubacher, Florian ;
Weidolf, Lars .
DRUG METABOLISM REVIEWS, 2007, 39 (01) :61-86
[3]
ESTIMATING HUMAN ORAL FRACTION DOSE ABSORBED - A CORRELATION USING RAT INTESTINAL-MEMBRANE PERMEABILITY FOR PASSIVE AND CARRIER-MEDIATED COMPOUNDS [J].
AMIDON, GL ;
SINKO, PJ ;
FLEISHER, D .
PHARMACEUTICAL RESEARCH, 1988, 5 (10) :651-654
[4]
A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[5]
SELECTIVE PARACELLULAR PERMEABILITY IN 2 MODELS OF INTESTINAL-ABSORPTION - CULTURED MONOLAYERS OF HUMAN INTESTINAL EPITHELIAL-CELLS AND RAT INTESTINAL SEGMENTS [J].
ARTURSSON, P ;
UNGELL, AL ;
LOFROTH, JE .
PHARMACEUTICAL RESEARCH, 1993, 10 (08) :1123-1129
[6]
The drug efflux-metabolism alliance: biochemical aspects [J].
Benet, LZ ;
Cummins, CL .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 :S3-S11
[7]
Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models [J].
Berggren, S ;
Hoogstraate, J ;
Fagerholm, U ;
Lennernäs, H .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (04) :553-560
[8]
Regional transport and metabolism of roivacaine and its CYP3A4 metabolite PPX in human intestine [J].
Berggren, S ;
Lennernäs, P ;
Ekelund, M ;
Weström, B ;
Hoogstraate, J ;
Lennernäs, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (07) :963-972
[9]
Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine [J].
Berggren, Sofia ;
Gall, Christine ;
Wollnitz, Nadine ;
Ekelund, Mats ;
Karlbom, Urban ;
Hoogstraate, Janet ;
Schrenk, Dieter ;
Lennernas, Hans .
MOLECULAR PHARMACEUTICS, 2007, 4 (02) :252-257
[10]
BERGMAN E, 2007, INT J PHARM